Disclosed is an application of a binding molecule for specific binding of a precursor for brain-derived neurotrophic factor (proBDNF). The binding molecule for proBDNF is particularly a monoclone antibody of proBDNF, and can be used to prevent, mitigate or treat autoimmune diseases.